0001074140-16-000003.txt : 20160823 0001074140-16-000003.hdr.sgml : 20160823 20160823124305 ACCESSION NUMBER: 0001074140-16-000003 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160810 FILED AS OF DATE: 20160823 DATE AS OF CHANGE: 20160823 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001018735 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 BUSINESS PHONE: 1-800-936-9669 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danielsen Erik CENTRAL INDEX KEY: 0001682873 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12033 FILM NUMBER: 161846813 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD CITY: ST LAURENT STATE: A8 ZIP: H4M 2V2 3 1 primary_doc.xml PRIMARY DOCUMENT X0206 3 2016-08-10 0 0001018735 NYMOX PHARMACEUTICAL CORP NYMX 0001682873 Danielsen Erik 9900 CAVENDISH BLVD ST LAURENT A8 H4M 2V2 QUEBEC, CANADA 0 1 0 0 Chief Financial Officer Common Stock 9900 D Erik Danielsen 2016-08-23